These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1395 related articles for article (PubMed ID: 33980943)

  • 1. The lower respiratory tract microbiome of critically ill patients with COVID-19.
    Gaibani P; Viciani E; Bartoletti M; Lewis RE; Tonetti T; Lombardo D; Castagnetti A; Bovo F; Horna CS; Ranieri M; Viale P; Re MC; Ambretti S
    Sci Rep; 2021 May; 11(1):10103. PubMed ID: 33980943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
    Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
    mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida spp.
    Viciani E; Gaibani P; Castagnetti A; Liberatore A; Bartoletti M; Viale P; Lazzarotto T; Ambretti S; Lewis R; Cricca M
    Int J Infect Dis; 2022 Apr; 117():233-240. PubMed ID: 35150910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Microbiota Predict Clinical Outcomes in Critically Ill Patients.
    Dickson RP; Schultz MJ; van der Poll T; Schouten LR; Falkowski NR; Luth JE; Sjoding MW; Brown CA; Chanderraj R; Huffnagle GB; Bos LDJ;
    Am J Respir Crit Care Med; 2020 Mar; 201(5):555-563. PubMed ID: 31973575
    [No Abstract]   [Full Text] [Related]  

  • 5. Lung microbiome on admission in critically ill patients with acute bacterial and viral pneumonia.
    Marimón JM; Sorarrain A; Ercibengoa M; Azcue N; Alonso M; Vidaur L
    Sci Rep; 2023 Oct; 13(1):17724. PubMed ID: 37853062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome.
    Sulaiman I; Chung M; Angel L; Tsay JJ; Wu BG; Yeung ST; Krolikowski K; Li Y; Duerr R; Schluger R; Thannickal SA; Koide A; Rafeq S; Barnett C; Postelnicu R; Wang C; Banakis S; Pérez-Pérez L; Shen G; Jour G; Meyn P; Carpenito J; Liu X; Ji K; Collazo D; Labarbiera A; Amoroso N; Brosnahan S; Mukherjee V; Kaufman D; Bakker J; Lubinsky A; Pradhan D; Sterman DH; Weiden M; Heguy A; Evans L; Uyeki TM; Clemente JC; de Wit E; Schmidt AM; Shopsin B; Desvignes L; Wang C; Li H; Zhang B; Forst CV; Koide S; Stapleford KA; Khanna KM; Ghedin E; Segal LN
    Nat Microbiol; 2021 Oct; 6(10):1245-1258. PubMed ID: 34465900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent airway microbiomes in lung transplant recipients with or without pulmonary infection.
    Påhlman LI; Manoharan L; Aspelund AS
    Respir Res; 2021 Apr; 22(1):118. PubMed ID: 33892717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of Conventional Culture and MALDI-TOF MS for Identification of Microbial Communities in Bronchoalveolar Lavage Fluid in Comparison with the GS Junior Next Generation Sequencing System.
    Sung JY; Hwang Y; Shin MH; Park MS; Lee SH; Yong D; Lee K
    Ann Lab Med; 2018 Mar; 38(2):110-118. PubMed ID: 29214754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients.
    Soltani S; Zakeri A; Zandi M; Kesheh MM; Tabibzadeh A; Dastranj M; Faramarzi S; Didehdar M; Hafezi H; Hosseini P; Farahani A
    Biomed Res Int; 2021; 2021():6670798. PubMed ID: 33681368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study.
    Lahmer T; Kriescher S; Herner A; Rothe K; Spinner CD; Schneider J; Mayer U; Neuenhahn M; Hoffmann D; Geisler F; Heim M; Schneider G; Schmid RM; Huber W; Rasch S
    PLoS One; 2021; 16(3):e0238825. PubMed ID: 33730058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-Infections in Critically Ill Patients with or without COVID-19: A Comparison of Clinical Microbial Culture Findings.
    Cultrera R; Barozzi A; Libanore M; Marangoni E; Pora R; Quarta B; Spadaro S; Ragazzi R; Marra A; Segala D; Volta CA
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33923992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal multicompartment characterization of host-microbiota interactions in patients with acute respiratory failure.
    Kitsios GD; Sayed K; Fitch A; Yang H; Britton N; Shah F; Bain W; Evankovich JW; Qin S; Wang X; Li K; Patel A; Zhang Y; Radder J; Dela Cruz C; Okin DA; Huang CY; Van Tyne D; Benos PV; Methé B; Lai P; Morris A; McVerry BJ
    Nat Commun; 2024 Jun; 15(1):4708. PubMed ID: 38830853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Gut Microbiota of Critically Ill Patients With COVID-19.
    Gaibani P; D'Amico F; Bartoletti M; Lombardo D; Rampelli S; Fornaro G; Coladonato S; Siniscalchi A; Re MC; Viale P; Brigidi P; Turroni S; Giannella M
    Front Cell Infect Microbiol; 2021; 11():670424. PubMed ID: 34268136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of a multiplex polymerase chain reaction panel for identifying bacterial pathogens causing pneumonia in critically ill patients with COVID-19.
    Caméléna F; Moy AC; Dudoignon E; Poncin T; Deniau B; Guillemet L; Le Goff J; Budoo M; Benyamina M; Chaussard M; Coutrot M; Lafaurie M; Plaud B; Mebazaa A; Depret F; Berçot B
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115183. PubMed ID: 33069002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbapenem-resistant Klebsiella pneumoniae in ICU-admitted COVID-19 patients: Keep an eye on the ball.
    Montrucchio G; Corcione S; Sales G; Curtoni A; De Rosa FG; Brazzi L
    J Glob Antimicrob Resist; 2020 Dec; 23():398-400. PubMed ID: 33242674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
    Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
    J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human microbiome and COVID-19: A systematic review.
    Yamamoto S; Saito M; Tamura A; Prawisuda D; Mizutani T; Yotsuyanagi H
    PLoS One; 2021; 16(6):e0253293. PubMed ID: 34161373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive microbiological respiratory tract specimen characterization in critically ill COVID-19 patients.
    Thomsen K; Pedersen HP; Iversen S; Wiese L; Fuursted K; Nielsen HV; Christensen JJE; Nielsen XC
    APMIS; 2021 Jul; 129(7):431-437. PubMed ID: 33950572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 influences lung microbiota dynamics and favors the emergence of rare infectious diseases: A case report of Hafnia Alvei pneumonia.
    Cutuli SL; De Maio F; De Pascale G; Grieco DL; Monzo FR; Carelli S; Tanzarella ES; Pintaudi G; Piervincenzi E; Cascarano L; Xhemalaj R; Sanguinetti M; Posteraro B; Spanu T; Antonelli M
    J Crit Care; 2021 Aug; 64():173-175. PubMed ID: 33957578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent Legionnaires' Disease and Associated Antibiotic Treatment Engender a Highly Disturbed Pulmonary Microbiome Enriched in Opportunistic Microorganisms.
    Pérez-Cobas AE; Ginevra C; Rusniok C; Jarraud S; Buchrieser C
    mBio; 2020 May; 11(3):. PubMed ID: 32430469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.